In comparison with normal cells, cancer cells have an enhanced ability to trap both nitrogen and energy; an enhanced operation of the glycolytic and direct oxidative pathways, leading to accumulation of lactate and increased production of NADPH; and a greater content of lysosomal hydrolases. These changes represent a reprogramming of gene expression, which, at its most specific, is accompanied by the reappearance in the cell and ultimately in the body fluids of oncodevelopmental proteins not normally found in mature adult tissues. The most florid stage of this reprogramming leads to the metastatic phenotype, which confers upon the cancer cell the ability to stimulate angiogenesis, invade the bloodstream and lymphatic vessel, and arrest and proliferate in distant tissues. The diagnostic implications of these phenotypic changes are illustratedfor cancer of the cervix uteri and cancer of the colon. We also review the classical theories of neoplasia, including the cellular anoxia concept of Warburg, the deletion hypothesisof Potter, and various other mechanisms emphasizing genomic derepression and impaired immunity. The critical steps in chemical carcinogenesis are described, and the Vogelstein-Lane model is presented, emphasizing the stepwise and cumulative genomic changes affecting chromosomes 5q, 17p, 18q, and gene amplification of chromosome 12 as well as genomic instability resulting from reduced DNA methylation. The main consequences of these genomic alterations include overexpression or activation of oncogenes such as c-myc and k-ras, together with mutation or functional inactivation of suppressor genes such as p53. Finally, the implications of these findings for diagnosis and management are illustrated by reference to recent investigations in cancers of the breast, colon, and bladder, in which these genomic alterations can be detected by examination of appropriate cellular material and by detection in serum of antibodiesto the p53 gene product. 
which is often high even under aerobic conditions, leading to high rates of lactic acid production (8,9) and a fall in the pH of the tumor tissue (10), and activity of the direct oxidative pathway, otherwise known as the hexose monophosphate shunt (11-13). The latter is important in the economy of the cancer cell by contributing in a major way to the production of NADPH, which is necessary for nucleic acid synthesis. Lipid metabolism. A dramatic reduction in body fat content is invariably found in terminal cancer patients (14) . This, together with the effects of prolonged negative nitrogen balance and protein wasting, leads to the clinical picture of cachexia. The factors that induce this state are multiple and complex and involve endocrine and nutritional mechanisms that operate at the level of the host rather than of the cancer cell (15) .
Lysosomd hydrolases. An excess of lysosome8 is often found in cancer cells (16). This confers a selective advantage, in that intracellular digestion is enhanced, and is likely to prove nutritionally beneficial to cancer cells.
These enzymes probably also play an important role in the local spread of the tumor and in its abifity to metastasize.
The MolecularCorrelationConcept
This concept was proposed by George Weber on the basis of a monumental series of investigations summarized in his Clowes Memorial Lecture in 1983 (17). To this day, it stands as the most comprehensive characterization of the cancer cell in terms of its metabolic behavior. Comparing normal tissues (mainly liver) with a series of tumors of varying but defined growth rates (mainly hepatomas), he recognized that certain key enzymes are tightly coupled with either neoplastic transformation or with progression of the tumor by alterations in their activity, concentration, or isoenzyme proffle. These key changes, shared in greater or lesser measure by all cancer cells, depending on their grade of malignancy, proliferative rate, and degree of differentiation, could be distinguished from coincidental changes in gene expression not strictly linked with neoplasia. An example of this approach is illustrated in Figure 1 . The overall changes in gluconeogenic enzymes typical of cancers are summarized in Table 2 .
Although Weber Table 4 , contribute to this process. ducted an intensive study of this possibility for more than a decade (33) (34) (35) (36) (37) (38) . Beginning with the characterization of enzymes in the tumor tissue in comparison with normal cervical mucosa, they showed that high were also present (35) (36) (37) (38) . Finally, an increase in membrane-related enzymes was also a prominent feature, as illustrated by GGT in Figure 2 . These differences were evident when the vaginal fluid content of cancer patients was compared with that of normal healthy women (Figure 3) 
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The VogeisteinModel
This is the most recent model to be proposed concerning the origin and development of cancer cells (103). Unlike most of the earlier models, it is based on observations in human cancer, the best-documented being cancer of the colon. In fact, the elements in this hypothesis are really not new; what is novel is the specific Fig. 4 . Genetic model for colorectal tumorigenesis Tumorigenesis proceeds through a series of genetic alterations involvingoncogenes (ras)and tumor-suppressorgenes (particulally those on chromosomes5q, 17p, and 18q). Patients with familial adenomatous polyposis (FAP) inherit a mutation on chromosome 5q, an alteration that may be responsible for the hyperproifferativeepitheliuminthese patients.In tumorsarising inpatientswithout polyposis,the same regionmay also be lost and (or) mutated at a relatively early stage of tumorigenesis.Hypomethylation ispresentin very small adenomasin patientswithorwithout polyposis,an alterationthat may lead to aneuploidy,resulting in thelossofsuppressor gene alleles. ras gene mutation appears to occur In one cell of a preexistingsmall adenoma and, through clonal expansion, produces a larger and more dysplastic tumor. The chromosomes most frequently deleted Indude 5q, 17p, and iBq; the putative targetof the loss event (I.e., the tumor-suppressorgene) on each chromosomeisindicatedas wellas the relativetiming of thechromosome lossevent.The orderofthesechangesIsnotlnvariant and accumulation ofthese changes,rather than their order with respectto one another,seems most Important From: Fearon and Vogeistein (103) . Reprintedwith permissionfromthe authors and Cell Press will be benign or malignant. However, certain changes do have a tendency to appear in a sequential order.
Thus, as shown in Figure 5 , ras mutation tended to occur earlier than loss of p53 suppressor activity, as determined by chromosome l'Tp deletions.
5.
The hypothesis emphasizes the primacy of tumorsuppressorgene inactivation, which, even in the heterozygous state, is able to exert a "dominant negative" effect. This aspect of the hypothesis has been strongly emphasized by Lane (102), who refers top53 protein as the "guardian of the genome."
To better understand these concepts, a word of explanation is necessary.
p53 is believed to function as a tetramer that binds to p53-specific genomic sites to stimulate the expression of genes that inhibit growth and (or) invasion (Figure 7 ). Loss of one or both p53
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ALTERATION alleles may occur in some tumors by chromosomal defects or deletions (Figure 7-1) . Truncation of p53 by a "nonsense" mutation may cause loss of the oligomerization domain and prevent the formation of tetramers (Figure 7-2 ). This will reduce the number of functional tetramers by about half. Paradoxically, a "missense" mutation allows the abnormal peptide to participate in the formation of tetramers; however, these tetramers will be nonfunctional and will result in a much greater impairment of growth regulation, because mutant wildtype tetramers do not function normally. This dominant negative effect may be enhanced by the greater stability of the mutant protein, which will therefore attain a higher intracellular concentration than the wild-type protein will (Figure 7-3) . As already mentioned, a missense mutation of one p53 allele often coexists with n-rn n-rn 
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ConclusIon
Cancer research has never been so exciting as at the present time. New concepts and the explosive growth in knowledge of the human genome and how it functions have spawned an array of molecular procedures whose potential is awesome but which at present are of limited practical utility. Table 9 
